Method for inhibiting inflammation and pre-inflammatory cytokine/chemokine expression using a ghrelin analogue

Details for Australian Patent Application No. 2008284269 (hide)

Owner IPSEN Pharma S.A.S.

Inventors Taylor, John E.; Dong, Zheng Xin; Culler, Michael Dewitt; Datta, Rakesh

Agent Griffith Hack

Pub. Number AU-A-2008284269

PCT Pub. Number WO2009/020643

Priority 60/963,951 08.08.07 US

Filing date 7 August 2008

Wipo publication date 12 February 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

18 March 2010 PCT application entered the National Phase

  PCT publication WO2009/020643 Priority application(s): WO2009/020643

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008284271-Matriptase protein and uses thereof

2008284268-Pyridine carboxamide orexin receptor antagonists